Cover Image

Neutralization against XBB.1 and XBB.1.5 after omicron subvariants breakthrough infection or reinfection

Saved in:

Bibliographic Details
Main Authors:	Jin-Jin Chen (Author), Li-Bo Li (Author), Hong-Hong Peng (Author), Shen Tian (Author), Bin Ji (Author), Chao Shi (Author), Cheng Qian (Author), Wen-Guo Jiang (Author), Mei-Chen Liu (Author), Ting-Ting Li (Author), Yuan Shen (Author), Li-Qun Fang (Author), Guo-Lin Wang (Author)
Format:	Book
Published:	Elsevier, 2023-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The epidemiology and phylogenetic trends of Omicron subvariants from BA.5 to XBB.1 in Taiwan
by: Jih-Jin Tsai, et al.
Published: (2024)

Severity of SARS-CoV-2 Omicron XBB subvariants in Singapore
by: Rachael Pung, et al.
Published: (2023)

Severity of COVID-19 sub-lineages XBB/XBB 1.5/XBB1.16, EG.5.1. and JN.1. in England
by: Catherine Quinot, et al.
Published: (2024)

XBB.1.5 emerges in the Americas: what it means to the region
by: Peter Hotez
Published: (2023)

Prevalence of SARS-CoV-2 Omicron variants and epidemiological characteristics of subvariant XBB infections in Pudong New Area, Shanghai during January - June 2023
by: Yilin JIA, et al.
Published: (2023)

Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection
by: Xiaosu Chen, et al.
Published: (2023)

Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine
by: Wanting Li, et al.
Published: (2023)

XBB.1, BQ1.1 and atypical BA.4.6/XBB.1 recombinants predominate current SARS-CoV-2 Wavelets with flu-like symptoms in Cameroon: A snapshot from genomic surveillance
by: Joseph Fokam, et al.
Published: (2024)

Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1
by: Fanglei Zuo, et al.
Published: (2023)

High Transferability of Neutralizing Antibodies against SARS-CoV-2 to Umbilical Cord Blood in Pregnant Women Vaccinated with BNT162b2 XBB.1.5: A Retrospective Cohort Study
by: Takuma Hayashi, et al.
Published: (2024)

In silico prediction of siRNA to silence the SARS-CoV-2 omicron variant targeting BA.4, BA.5, BQ.1, BQ1.1. and XBB: an alternative to traditional therapeutics
by: Rahatul Islam, et al.
Published: (2023)

Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ.1.1 and XBB, in a very elderly population
by: Silvia Sutandhio, et al.
Published: (2023)

Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study
by: Baltazar Nunes, et al.
Published: (2024)

Emergence of XBB.1.16-a new recombinant COVID-19 variant driving the surge of COVID-19 cases in India
by: Tarun Kumar Suvvari, et al.
Published: (2023)

Can the RBD mutation R346X provide an additional fitness to the "variant soup," including offspring of BQ and XBB of SARS-CoV-2 Omicron for the antibody resistance?
by: Srijan Chatterjee, et al.
Published: (2023)

Neutralizing activity of a third dose of CoronaVac against Omicron subvariants within a 20-month follow-up study
by: Cheng Cao, et al.
Published: (2023)

The serological IgG and neutralizing antibody of SARS-CoV-2 omicron variant reinfection in Jiangsu Province, China
by: Jinjin Chu, et al.
Published: (2024)

Clinical Profile and Outcome Analysis of Ear-Nose-Throat Symptoms in SARS-CoV-2 Omicron Subvariant Infections
by: Yixuan Liu, et al.
Published: (2023)

COVID-19 hospitalisations in a tertiary health service during the Omicron subvariant wave
by: Alysha Y. Wanigaratne, et al.
Published: (2024)

Omicron subvariant BA.5 is highly contagious but containable: Successful experience from Macau
by: Cong Xu, et al.
Published: (2023)

Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants
by: Chiranjib Chakraborty, et al.
Published: (2023)

Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection
by: Huiling Zheng, et al.
Published: (2024)

An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China
by: Meiling Zhang, et al.
Published: (2022)

SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023
by: Mengyan Zhang, et al.
Published: (2024)

Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
by: Srijan Chatterjee, et al.
Published: (2023)

SARS-CoV-2 reinfections with BA.1 (Omicron) variant among fully vaccinated individuals in northeastern Brazil.
by: Francisco P Freire-Neto, et al.
Published: (2022)

Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages
by: Bradley K. Ackerson, et al.
Published: (2024)

Characteristics of Omicron variant-induced SARS-CoV-2 reinfections in Chengdu, China
by: Yingxue DAI, et al.
Published: (2023)

As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?
by: Ren Xu, et al.
Published: (2022)

Reinfection in patients with COVID-19: a systematic review
by: Xiangying Ren, et al.
Published: (2022)

SARS-CoV-2 in Malaysia: A surge of reinfection during the predominantly Omicron period
by: Su Lan Yang, et al.
Published: (2022)

SARS-CoV-2 vaccine breakthrough reinfection in a health-care worker of Iraq: A case report
by: Dlshad Abdullah Hasan, et al.
Published: (2022)

Immediate reinfection with Omicron variant after clearance of a previous SARS-CoV-2 infection
by: Antonella Mencacci, et al.
Published: (2022)

Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant
by: Anita M. Shete, et al.
Published: (2022)

Statement on healthcare system preparedness in response to COVID-19 Omicron subvariants BA.4 and BA.5 surge in Korea from the Korean Pediatric Society and Korean Society of Pediatric Infectious Diseases
by: Eun Young Cho, et al.
Published: (2022)

Fast-Spreading JN.1: What You Need to Know About the Latest COVID-19 Subvariant
by: Shriyansh Srivastava, et al.
Published: (2024)

Evaluation of cross-neutralizing antibodies in children infected with omicron sub-variants
by: Weiyu Peng, et al.
Published: (2023)

Primary and booster vaccination in reducing severe clinical outcomes associated with Omicron Naïve infection
by: Chen-Yang Hsu, et al.
Published: (2023)

Influenza A (H1N1) 2009 reinfection in Thailand
by: Satariya Trakulsrichai, et al.
Published: (2012)

Breakthrough cases of Omicron and Delta variants of SARS-CoV-2 during the fifth wave in Pakistan
by: Zunera Jamal, et al.
Published: (2022)